Attack on cancer cells.Attack on cancer cells cells once believed to be peculiar to cancers, but now know to be epithelial cells differing in no respect from those found elsewhere in the body, and distinguished only by peculiarity of location and grouping. See also: Cancer Interferon is being tested as an agent to fight cancers (SN: 7/27/85, p. 58) as well as viruses. Results reported by Gilbert Jay and his colleagues at the National Cancer Institute in Bethesda, Md., indicate how this natural chemical may help fight malignancies and suggest new means of bolstering the immune system's attack. Jay has been investigating the cancer-related role of the "classical transplantation antigens," those cell-surface proteins responsible for rejection of transplanted organs. He suggests cancer cells may evade the host immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. by omitting one group of these proteins, called class I antigens, from cell surfaces. Interferon's role, then, in fighting cancer may be to stimulate cancer cells to reveal their class I antigens, thereby making them better targets for immune attack Immune Attack is an educational video game created by the Federation of American Scientists and Brown University, in collaboration with the University of Southern California, under a grant from the National Science Foundation. . Jay used recombinant DNA recombinant DNA n. Genetically engineered DNA prepared by transplanting or splicing one or more segments of DNA into the chromosomes of an organism from a different species. Such DNA becomes part of the host's genetic makeup and is replicated. techniques to insert extra copies of the gene for a class I antigen into malignant (transformed) cells that do not normally show high levels of the surface proteins. The cells were no longer able to cause tumors. Treatment with interferon can also make malignant cells produce class I antigens. In animal experiments, the scientists injected malignant cells that normally cause tumors, then injected interferon. Jay says, "There was complete protection against this tumor tumor: see neoplasm. ." Another approach to the problem is to enhance the immune system's sensitivity to the scarce class I antigens that may be present on malignant cells. "The low level may be sufficient if the animal's immune system is angry enough," Jay says. He immunized animals with a dose of malignant cells treated with interferon (or given extra genes of a class I antigen). He also injected the animals with malignant cells of the same type but which had not undergone antigen-producing treatment. Instead of developing fast-growing tumors, the animals remained healthy. The immunization immunization: see immunity; vaccination. was successfully given a week before, on the same day or two days after injection of the malignant cells. Jay speculates that it may be possible to immunize im·mu·nize v. 1. To render immune. 2. To produce immunity in, as by inoculation. im patients against their own tumor cells. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion